A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964

被引：0
|
作者：
Amy L. Shafrir
Helena Schock
Elizabeth M. Poole
Kathryn L. Terry
Rulla M. Tamimi
Susan E. Hankinson
Bernard A. Rosner
Shelley S. Tworoger
机构：
[1] Boston Children’s Hospital,Division of Adolescent/Young Adult Medicine, Boston Center for Endometriosis
[2] Harvard Medical School,Department of Pediatrics
[3] German Cancer Research Center,Division of Cancer Epidemiology
[4] Brigham and Women’s Hospital and Harvard Medical School,Channing Division of Network Medicine, Department of Medicine
[5] Harvard T.H. Chan School of Public Health,Department of Epidemiology
[6] Brigham and Women’s Hospital and Harvard Medical School,Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology
[7] University of Massachusetts,Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences
[8] Harvard T.H. Chan School of Public Health,Department of Biostatistics
来源：
Cancer Causes & Control | 2017年 / 28卷
关键词：
Oral contraceptives; Ovarian cancer; Ethinyl estradiol; Mestranol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：371 / 383
页数：12
相关论文
共 50 条
  • [1] A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964
    Shafrir, Amy L.
    Schock, Helena
    Poole, Elizabeth M.
    Terry, Kathryn L.
    Tamimi, Rulla M.
    Hankinson, Susan E.
    Rosner, Bernard A.
    Tworoger, Shelley S.
    CANCER CAUSES & CONTROL, 2017, 28 (05) : 371 - 383
  • [2] Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947–1964: The Nurses’ Health Study II, a prospective cohort study
    Norah A. Burchardt
    Amy L. Shafrir
    Rudolf Kaaks
    Shelley S. Tworoger
    Renée T. Fortner
    European Journal of Epidemiology, 2021, 36 : 827 - 839
  • [3] Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study
    Burchardt, Norah A.
    Shafrir, Amy L.
    Kaaks, Rudolf
    Tworoger, Shelley S.
    Fortner, Renee T.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2021, 36 (08) : 827 - 839
  • [4] Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: A prospective cohort study
    Silvera, SAN
    Miller, AB
    Rohan, TE
    CANCER CAUSES & CONTROL, 2005, 16 (09) : 1059 - 1063
  • [5] Oral Contraceptive Use and Risk of Breast Cancer among Women with a Family History of Breast Cancer: a Prospective Cohort Study
    Stephanie A. N. Silvera
    Anthony B. Miller
    Thomas E. Rohan
    Cancer Causes & Control, 2005, 16 : 1059 - 1063
  • [6] A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States)
    Hankinson, SE
    Colditz, GA
    Manson, JE
    Willett, WC
    Hunter, DJ
    Stampfer, MJ
    Speizer, FE
    CANCER CAUSES & CONTROL, 1997, 8 (01) : 65 - 72
  • [7] A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States)
    Susan E. Hankinson
    Graham A. Colditz
    JoAnn E. Manson
    Walter C. Willett
    David J. Hunter
    Meir J. Stampfer
    Frank E. Speizer
    Cancer Causes & Control, 1997, 8 : 65 - 72
  • [8] Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women
    Hunter, David J.
    Colditz, Graham A.
    Hankinson, Susan E.
    Malspeis, Susan
    Spiegelman, Donna
    Chen, Wendy
    Stampfer, Meir J.
    Willett, Walter C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (10) : 2496 - 2502
  • [9] Contraindications to oral contraceptive use among women in the United States, 1999-2001
    Shortridge, Emily
    Miller, Kate
    CONTRACEPTION, 2007, 75 (05) : 355 - 360
  • [10] BREAST-CANCER AMONG YOUNG UNITED-STATES WOMEN IN RELATION TO ORAL-CONTRACEPTIVE USE
    WHITE, E
    MALONE, KE
    WEISS, NS
    DALING, JR
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07): : 505 - 514
12345